Abstract:ABSTRACT The cellular innate immune system recognizing pathogen infection is essential for host defense against viruses. In parallel, viruses have developed a variety of strategies to evade the innate immunity. The hepatitis B virus (HBV), a DNA virus that causes chronic hepatitis, has been shown to inhibit RNA helicase RIG-I-mediated interferon (IFN) induction. However, it is still unknown whether HBV could affect the host DNA-sensing pathways. Here we report that in transiently HBV-transfected Huh7 cells, the stably HBV-producing cell line HepAD38, and HBV-infected HepaRG cells and primary human hepatocytes, HBV markedly interfered with IFN-β induction and antiviral immunity mediated by the stimulator of interferon genes (STING), which has been identified as a central factor in foreign DNA recognition and antiviral innate immunity. Screening analysis demonstrated that the viral polymerase (Pol), but not other HBV-encoded proteins, was able to inhibit STING-stimulated interferon regulatory factor 3 (IRF3) activation and IFN-β induction. Moreover, the reverse transcriptase (RT) and the RNase H (RH) domains of Pol were identified to be responsible for the inhibitory effects. Furthermore, Pol was shown to physically associate with STING and dramatically decrease the K63-linked polyubiquitination of STING via its RT domain without altering the expression level of STING. Taken together, these observations suggest that besides its inherent catalytic function, Pol has a role in suppression of IFN-β production by direct interaction with STING and subsequent disruption of its K63-linked ubiquitination, providing a new mechanism for HBV to counteract the innate DNA-sensing pathways. IMPORTANCE Although whether and how HBV infection induces the innate immune responses are still controversial, it has become increasingly clear that HBV has developed strategies to counteract the pattern recognition receptor-mediated signaling pathways. Previous studies have shown that type I IFN induction activated by the host RNA sensors could be inhibited by HBV. However, it remains unknown whether HBV as a DNA virus utilizes evasion mechanisms against foreign DNA-elicited antiviral signaling. In recent years, the cytosolic DNA sensor and key adaptor STING has been demonstrated to be essential in multiple foreign DNA-elicited innate immune signalings. Here, for the first time, we report STING as a new target of HBV to antagonize IFN induction and identify the viral polymerase responsible for the inhibitory effect, thus providing an additional molecular mechanism by which HBV evades the innate immunity; this implies that in addition to its inherent catalytic function, HBV polymerase is a multifunctional immunomodulatory protein.

Hepatitis B virus polymerase inhibits RIGI-and Toll-like receptor 3-mediated beta interferon induction in human hepatocytes through interference with interferon regulatory factor 3 activation and dampening of the interaction between TBK 1 / IKK e and DDX 3

Hepatitis B virus polymerase inhibits RIG-I- and Toll-like receptor 3-mediated beta interferon induction in human hepatocytes through interference with interferon regulatory factor 3 activation and dampening of the interaction between TBK1/IKKϵ and DDX3

Hepatitis B Virus Polymerase Inhibits Rig-I- And Toll-Like Receptor 3-Mediated Beta Interferon Induction In Human Hepatocytes Through Interference With Interferon Regulatory Factor 3 Activation And Dampening Of The Interaction Between Tbk1/Ikk Epsilon And Ddx3

JAK/STAT Signaling is Involved in IL-35-induced Inhibition of Hepatitis B Virus Antigen-Specific Cytotoxic T Cell Exhaustion in Chronic Hepatitis B

Interferon-Inducible Myd88 Protein Inhibits Hepatitis B Virus Replication

HBV Inhibits LPS-induced NLRP3 Inflammasome Activation and IL-1β Production Via Suppressing the NF-κB Pathway and ROS Production.

Hepatitis B Virus Inhibits Intrinsic RIG-I and RIG-G Immune Signaling Via Inducing Mir146a

Hepatitis B Virus Polymerase Disrupts K63-Linked Ubiquitination of STING to Block Innate Cytosolic DNA-Sensing Pathways

Hepatitis B Virus Polymerase Inhibits the Interferon-Inducible MyD88 Promoter by Blocking Nuclear Translocation of Stat1

Hepatitis B Virus Polymerase Impairs Interferon-Α-induced STA T Activation Through Inhibition of Importin-Α5 and Protein Kinase C-δ

Interferon-alpha responsible EPN3 regulates hepatitis B virus replication

Role of interferon-stimulated gene factor 3 in inhibition of hepatitis B virus replication in vitro by interferon-α

An HBV-encoded miRNA activates innate immunity to restrict HBV replication

Hepatitis B Virus Surface Antigen Selectively Inhibits TLR2 Ligand–Induced IL-12 Production in Monocytes/Macrophages by Interfering with JNK Activation

INTERLEUKIN-33 INHIBITS HEPATITIS B VIRUS REPLICATION IN THE LIVERS OF TRANSGENIC MICE

Interleukin-33 Mediates Both Immune-Related and Non-Immune-related Inhibitory Effects Against Hepatitis B Virus

Role of ISGF3 in modulating the anti-hepatitis B virus activity of interferon-alpha in vitro.

The full length hepatitis C virus polyprotein and interactions with the interferon-beta signalling pathways in vitro

DNA-dependent Activator of Interferon-Regulatory Factors Inhibits Hepatitis B Virus Replication

Hepatitis B Virus e Antigen Activates the Suppressor of Cytokine Signaling 2 to Repress Interferon Action

Direct antiviral properties of TLR ligands against HBV replication in immune-competent hepatocytes